71 – 80 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
(
- Contribution to journal › Article
-
Mark
NEUROPEPTIDE AND HYPOTHALAMUS CHANGES IN FRONTOTEMPORAL DEMENTIA AND HUNTINGTON'S DISEASE
2010) 10th Biennial Meeting of the Asia-Pacific Society of Neurochemistry In Journal of Neurochemistry 115(Suppl. 1). p.1-1(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
-
Mark
Malignt neuroleptikasyndrom--sällsynt diagnos med hög dödlighet.
(
- Contribution to journal › Scientific review
-
Mark
Huntington's Disease - New Perspectives Based on Neuroendocrine Changes in Rodent Models.
(
- Contribution to journal › Article
-
Mark
Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
(
- Contribution to journal › Article